8-K 1 d8k.htm FORM 8-K Form 8-K

 

UNITED STATES OF AMERICA

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

Current Report

Pursuant To Section 13 Or 15(d) Of The

Securities Exchange Act Of 1934

 

 

March 11, 2004

Date of Report

(Date of Earliest Reported Event)

 

 

HI-TECH PHARMACAL CO., INC.

(Exact name of registrant as specified in its charter)

 

 

Commission File No. 0-20424

 

 

Delaware   11-2638720
(State or other jurisdiction of incorporation)   (IRS Employer Identification No.)

 

 

369 Bayview Avenue   Amityville, NY 11701
(Address of principal executive offices)   (Zip Code)

 

 

(631) 789-8228

Registrant’s telephone number, including area code:

 



ITEM 12.     RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

The Registrant issued a press release, dated March 11, 2004, announcing its financial results for the third quarter of its fiscal 2004 year ended January 31, 2004. The text of the press release is attached hereto as Exhibit 99.1.


EXHIBIT INDEX

 

Number

  

Description


99.1    Press Release issued by Hi-Tech Pharmacal Co., Inc. on March 11, 2004.

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 11, 2004       HI-TECH PHARMACAL CO., INC.
            Name:   /S/    DAVID S. SELTZER
               
            Title:  

President and

Chief Executive Officer